title: Review on ultrasound measurement of bladder or detrusor wall thickness in women: techniques, diagnostic utility, and use in clinical trials.
abstract: OBJECTIVE
  To provide a narrative review of literature evaluating ultrasound techniques for the measurement of bladder wall hypertrophy in women as an alternative to invasive urodynamic assessment for the diagnosis of lower urinary tract symptoms (LUTS).
  
  
  METHODS
  A literature review was performed using PubMed and all paper journals of congress abstracts searching for articles on ultrasound measurement of bladder wall thickness (BWT) or detrusor wall thickness (DWT) published between January 1990 and May 2012. Each study was classified with a level of evidence using the Oxford Centre for Evidence-based Medicine classification (2009).
  
  
  RESULTS
  Ultrasound measurement of bladder wall hypertrophy is not standardised, and techniques vary widely according to anatomical approach, ultrasound frequency and other factors. This review compared transvaginal, translabial/transperineal and suprapubic approaches for ultrasound BWT/DWT measurement. BWT/DWT measurements correlated well with urodynamic diagnoses of detrusor overactivity (DO) using all three ultrasound techniques. BWT values were consistently higher in women with DO than in women with stress incontinence, although threshold values for the differential diagnosis of DO varied between clinical studies (5.0-6.5 mm using transvaginal ultrasound). Few data were available on the use of translabial or suprapubic ultrasound in women. Inter- and intraobserver variability was higher with transperineal and suprapubic ultrasound, and these techniques appear less reliable than transvaginal ultrasound. Studies suggest that BWT is reduced in response to antimuscarinic therapy in women with overactive bladder or DO.
  
  
  CONCLUSIONS
  Data from clinical trials suggest that transvaginal ultrasound measurement of BWT is a reliable method of diagnosing DO in women with LUTS, and BWT decreases during antimuscarinic therapy.
authors: Department of Urology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany, oelke.matthias@mh-hannover.de.
authors: Matthias
authors: M
authors: Oelke
authors: Vik
authors: V
authors: Khullar
authors: Hessel
authors: H
authors: Wijkstra
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D008875:Middle Aged; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D015588:Observer Variation; D015203:Reproducibility of Results; D016896:Treatment Outcome; D014463:Ultrasonography / Q000379:methods*; D001743:Urinary Bladder / Q000000981:diagnostic imaging*; D053201:Urinary Bladder, Overactive / Q000175:diagnosis* / Q000000981:diagnostic imaging* / Q000188:drug therapy; D055815:Young Adult
chemical_list: D018727:Muscarinic Antagonists
references: Neurourol Urodyn. 2010 Apr;29(4):634-9
references: 20432327
references: Aust N Z J Obstet Gynaecol. 2009 Dec;49(6):653-6
references: 20070717
references: Urology. 1997 Dec;50(6):934-40
references: 9426726
references: BJOG. 2002 Feb;109(2):145-8
references: 11888096
references: Ultrasound Obstet Gynecol. 2008 Sep;32(4):535-9
references: 18634113
references: Br J Obstet Gynaecol. 1996 Sep;103(9):904-8
references: 8813311
references: Neurourol Urodyn. 2002;21(5):461-3
references: 12232881
references: Neurourol Urodyn. 2007;26(2):176-82; discussion 183-4
references: 17016799
references: Int Urogynecol J. 2010 Jul;21(7):841-5
references: 20349178
references: Neurourol Urodyn. 2010;29(1):4-20
references: 19941278
references: J Urol. 2008 Jun;179(6):2275-8; discussion 2278-9
references: 18423703
references: J Ultrasound Med. 2003 Aug;22(8):777-82
references: 12901404
references: Ultrasound Obstet Gynecol. 1994 May 1;4(3):220-3
references: 12797185
references: J Urol. 1998 Jan;159(1):191-4
references: 9400470
references: Neurourol Urodyn. 2010 Mar;29(3):482-7
references: 19367641
references: Eur Urol. 2007 Sep;52(3):827-34
references: 17207910
references: Neurourol Urodyn. 2003;22(2):156-63
references: 12579634
references: Nat Rev Urol. 2011 Mar;8(3):139-45
references: 21321572
references: World J Urol. 2002 Apr;19(6):443-52
references: 12022713
references: BJU Int. 2010 Nov;106(10):1519-22
references: 20438565
references: Arch Gynecol Obstet. 2010 Jul;282(1):33-41
references: 20191279
references: Neurourol Urodyn. 1999;18(6):647-52
references: 10529713
references: J Urol. 2006 Sep;176(3):1166-70
references: 16890718
references: Adv Urol. 2011;2011:382431
references: 21687625
references: Neurourol Urodyn. 2010 Nov;29(8):1393-6
references: 20976813
references: Neurourol Urodyn. 2011 Mar;30(3):325-8
references: 20949598
references: Int Urogynecol J Pelvic Floor Dysfunct. 2009 Nov;20(11):1293-9
references: 19557300
references: Int Urogynecol J. 2010 Nov;21(11):1405-11
references: 20535449
references: J Ultrasound Med. 2002 Nov;21(11):1249-55
references: 12418766
references: Neurourol Urodyn. 2010 Sep;29(7):1295-8
references: 20127835
references: BJU Int. 2010 Mar;105(5):668-72
references: 19793377